In this episode of #MovingMedicineForward – The Podcast, CTI experts Chad Jones & Eric Clayton discuss challenges in clinical research surrounding Acute Myeloid Leukemia (AML) & Multiple Myeloma (MM). They explore the complexities of designing & conducting clinical trials, the importance of site selection, & how CTI’s expertise enhances trial outcomes. Additionally, they touch on key advancements to watch at the 66th American Society of Hematology Annual Meeting. During the episode, Eric explains how, “These are some of the first times that these therapies are being tried in human participants, & that innovative experimentation is what makes this work so exciting.”

0:22 Challenges in clinical research for Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM), with insights from CTI experts Chad Jones, Sr. Director of Project Management and Oncology Strategy Lead, and Eric Clayton, Clinical Project Manager III. 

0:51 Overview of AML and MM, and why these diseases are particularly difficult to treat. 

1:32 Key challenges in designing and conducting clinical trials for AML and MM. 

3:19 How site selection and management impact trial success, and challenges Contract Research Organizations (CROs) face when recruiting qualified sites. 

5:14 How CTI's expertise supports sponsors and improves trial outcomes. 

6:38 The importance of maintaining proper chain of custody. 

9:53 Key treatments and advancements in hematology to watch at the 66th ASH Annual Meeting. 

10:33 Visit CTI at booth #454 at ASH. 

10:41 Regulatory considerations for treatments and how CTI navigates this process for patients. 

12:31 Collaboration between CROs, pharmaceutical companies, and academic institutions to accelerate research. 

13:12 Unmet needs in AML and MM research and how the industry can address them. 

14:16 Challenges in improving patient outcomes for MM and AML. 

16:22 How CTI mitigates patient retention during clinical trials. 

18:33 Strategies for recruiting critically ill MM and AML patients. 

21:41 CTI is recruiting a Sr. Medical Director in Hematology/Oncology. Apply now: Senior Medical Director - Hematology/Oncology - Level Dependent Upon Experience | Join The CTI Team